Denator Expands Asian Distributor Network

News

Denator Expands Asian Distributor Network

02 Feb, 2015

Published over 11 years ago. See the latest and most current information on News.

Denator AB announced today that the company has appointed Aspec Technologies Ltd and DI Biotech Ltd as new distributors of its Stabilizor™ system in selected Asian markets. Under the terms of the agreements, ASPEC and DI Biotech will market, sell and provide support for Denator’s range of sample preservation products. ASPEC will cover the geographical markets of China, Hong Kong, Taiwan and Macau and DI Biotech will cover the Korean market. Together with Denator’s partner in Japan, AMR, and representative in India, MediAnalytika, the company now has an excellent cover of the core markets in Asia.

Denator’s proprietary heat-stabilisation technology is an additive-free preservation technology for biological samples which stops degradation and changes immediately and permanently. This ensures a stable sample from the moment of excision until the point of analysis which increases the accuracy and quality of analytical results.

Karsten Fjärstedt, VP Global Marketing and Sales at Denator, comments: “We are very happy to have such well-respected distributors as ASPEC and DI Biotech representing our products. This expansion of our distributor network will strengthen our presence in the important Asian market. During the spring Denator will, together with our new partners, conduct a sales tour and attend selected conferences in the region to drive the adoption of our heat-stabilisation technology.“

By using heat-stabilisation, scientists have been able to drastically improve the consistency of sample quality and discover new, biologically-relevant information without needing to use additives like inhibitors. This is of particular significance to research areas such as neuroscience, oncology and proteomic research, where short-lived molecules and potential biomarkers need to be confidently identified in order to understand disease mechanisms and identify potential drug targets or disease markers. Users typically include pharmaceutical companies, academic labs, clinical research facilities and biobanks.

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
EU ETS benchmark update puts industrial emissions data under sharper scrutiny
Explore more Arrow
Pollution Solutions Online
The Tire Industry Project launches real-world pilot to assess wastewater treatment for removing tire and road wear particles
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Non-invasive flowmeters for real-time monitoring
Explore more Arrow